Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4109 | 1769 | 42.3 | 90% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MOL TUMOR BIOL | Address | 53 | 52% | 4% | 72 |
2 | CELLULAR GENE THER IES | Address | 37 | 32% | 5% | 97 |
3 | IL 13 RECEPTOR | Author keyword | 35 | 86% | 1% | 18 |
4 | INTERLEUKIN 13 RECEPTOR | Author keyword | 35 | 86% | 1% | 18 |
5 | INTERLEUKIN 13 | Author keyword | 28 | 23% | 6% | 104 |
6 | BIOL EVALUAT NIH | Address | 23 | 100% | 1% | 10 |
7 | INTERLEUKIN 4 | Author keyword | 21 | 10% | 11% | 189 |
8 | IL 13 | Author keyword | 21 | 17% | 6% | 110 |
9 | TUMOR VACCINES BIOTECHNOL BRANCH | Address | 18 | 49% | 1% | 26 |
10 | STAT6 | Author keyword | 14 | 22% | 3% | 58 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IL 13 RECEPTOR | 35 | 86% | 1% | 18 | Search IL+13+RECEPTOR | Search IL+13+RECEPTOR |
2 | INTERLEUKIN 13 RECEPTOR | 35 | 86% | 1% | 18 | Search INTERLEUKIN+13+RECEPTOR | Search INTERLEUKIN+13+RECEPTOR |
3 | INTERLEUKIN 13 | 28 | 23% | 6% | 104 | Search INTERLEUKIN+13 | Search INTERLEUKIN+13 |
4 | INTERLEUKIN 4 | 21 | 10% | 11% | 189 | Search INTERLEUKIN+4 | Search INTERLEUKIN+4 |
5 | IL 13 | 21 | 17% | 6% | 110 | Search IL+13 | Search IL+13 |
6 | STAT6 | 14 | 22% | 3% | 58 | Search STAT6 | Search STAT6 |
7 | IL 13R ALPHA 2 | 14 | 65% | 1% | 13 | Search IL+13R+ALPHA+2 | Search IL+13R+ALPHA+2 |
8 | IL 13 RECEPTOR ALPHA 2 | 11 | 100% | 0% | 6 | Search IL+13+RECEPTOR+ALPHA+2 | Search IL+13+RECEPTOR+ALPHA+2 |
9 | IL 4 RECEPTOR | 10 | 35% | 1% | 23 | Search IL+4+RECEPTOR | Search IL+4+RECEPTOR |
10 | INTERLEUKIN 4 RECEPTOR | 10 | 35% | 1% | 22 | Search INTERLEUKIN+4+RECEPTOR | Search INTERLEUKIN+4+RECEPTOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IL 13 RECEPTOR | 83 | 76% | 3% | 59 |
2 | INTERLEUKIN 13 RECEPTOR | 66 | 57% | 4% | 78 |
3 | HUMAN INTERLEUKIN 4 RECEPTOR | 58 | 76% | 2% | 41 |
4 | CIRCULARLY PERMUTED INTERLEUKIN 4 | 49 | 94% | 1% | 17 |
5 | STIMULATORY FACTOR I | 49 | 25% | 10% | 174 |
6 | IL 4 RECEPTOR | 46 | 38% | 5% | 95 |
7 | RECOMBINANT HUMAN INTERLEUKIN 4 | 32 | 48% | 3% | 48 |
8 | PSEUDOMONAS EXOTOXIN | 31 | 20% | 8% | 137 |
9 | IL 4 RECEPTORS | 28 | 81% | 1% | 17 |
10 | RESTRICTIVE RECEPTOR | 27 | 83% | 1% | 15 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The IL-4 receptor: Signaling mechanisms and biologic functions | 1999 | 855 | 175 | 32% |
IL-13 effector functions | 2003 | 436 | 179 | 37% |
Interleukin-13 in asthma pathogenesis | 2004 | 346 | 98 | 36% |
IL-13 receptors and signaling pathways: An evolving web | 2003 | 237 | 150 | 50% |
INTERLEUKIN-13, AN INTERLEUKIN 4-LIKE CYTOKINE THAT ACTS ON MONOCYTES AND B-CELLS, BUT NOT ON T-CELLS | 1994 | 753 | 37 | 32% |
Cytokine Stimulation of Epithelial Cancer Cells: The Similar and Divergent Functions of IL-4 and IL-13 | 2012 | 17 | 30 | 73% |
Targeting of IL-4 and IL-13 receptors for cancer therapy | 2015 | 1 | 139 | 64% |
Interleukin-4-and Interleukin-13-Mediated Alternatively Activated Macrophages: Roles in Homeostasis and Disease | 2013 | 72 | 170 | 12% |
IL-13 receptor isoforms: Breaking through the complexity | 2007 | 27 | 55 | 82% |
Targeting Interleukin-4 in Asthma: Lost in Translation? | 2012 | 25 | 90 | 44% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL TUMOR BIOL | 53 | 52% | 4.1% | 72 |
2 | CELLULAR GENE THER IES | 37 | 32% | 5.5% | 97 |
3 | BIOL EVALUAT NIH | 23 | 100% | 0.6% | 10 |
4 | TUMOR VACCINES BIOTECHNOL BRANCH | 18 | 49% | 1.5% | 26 |
5 | SECT NEUROSURG H110 | 14 | 100% | 0.4% | 7 |
6 | BIOL EVALUAT FOOD DRUG ADM | 5 | 55% | 0.3% | 6 |
7 | INTERFERONS IMMUNOMODULATORS | 4 | 75% | 0.2% | 3 |
8 | PHARMAFOR PH R LSC NP | 3 | 100% | 0.2% | 3 |
9 | COMPREHENS COMMUNITY MED | 2 | 23% | 0.4% | 7 |
10 | JEROME HOLLAND S | 1 | 38% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000122534 | CANCER BIOTHERAPY//IST TIPIZZAZ TISSUTALE PROBLEMI DIALISI//INTRACELLULAR IMMUNOFLUORESCENCE |
2 | 0.0000092979 | T BET//GATA 3//HELPER T CELL DIFFERENTIATION |
3 | 0.0000089865 | INTERLEUKIN 5//IL 5//INTERLEUKIN 5 RECEPTOR |
4 | 0.0000075486 | CD23//SOLUBLE CD23//LOW AFFINITY IGE RECEPTOR |
5 | 0.0000070114 | ADAM33//ORMDL3//ASTHMA GENET GRP |
6 | 0.0000066989 | JOURNAL OF MOLECULAR AND CELLULAR IMMUNOLOGY//J11D//MED ICRF HUMAN TUMOUR IMMUNOL GRP |
7 | 0.0000065581 | IL 9//INTERLEUKIN 9//MAGAININ MOL MED |
8 | 0.0000064082 | INTERLEUKIN 2 RECEPTOR//IL 2 RECEPTOR//IL 2 RECEPTOR GAMMA CHAIN |
9 | 0.0000056397 | TOFACITINIB//JAK3//CP 690 550 |
10 | 0.0000052803 | GM CSF RECEPTOR//BLAST COLONIES//COMMON BETA SUBUNIT |